Delivery Order SPE2DB22D2108-SPE2DB24FU3VC
- Not listed
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has a ceiling value of $8,572.70 and is for the delivery of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. The ultimate completion date is April 24, 2023. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
- This is a delivery order award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., by the Defense Logistics Agency (DLA) Troop Support Medical. The $42,732.66 firm fixed-price contract is for the delivery of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a wide...
- This is a delivery order (SPE2DB22FM55R) awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., by the Defense Logistics Agency (DLA) Troop Support Medical. The $3,594.42 firm-fixed-price contract is for the delivery of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a...
- The U.S. government agency, the Defense Logistics Agency (DLA), awarded a Delivery Order contract valued at $2,944.99 to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of the pharmaceutical product XIFAXAN 550 MG TABLET 60S, with a completion date of December 11, 2023. This contract is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00...
- This federal contract award, valued at $10,925.98, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of the pharmaceutical product XIFAXAN 550 mg Tablet 60s. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. The IDC serves as a primary...
- The Defense Logistics Agency (DLA) awarded a $5,431.75 firm-fixed-price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of XIFAXAN 550 MG TABLET 60S. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $12,978.74, is for the delivery of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product. The contract has a ceiling value of $12,978.74 and an ultimate completion date of November 20, 2023. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc....
- This federal contract award, issued by the Defense Logistics Agency (DLA) Troop Support Medical, is a Delivery Order valued at $42,891.12 for the pharmaceutical product XIFAXAN 550 MG TABLET 60S. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026....
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the supply of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product, with a ceiling value of $5,462.73 and a completion date of May 10, 2024. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- The U.S. Defense Logistics Agency awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of parent company Cencora, Inc. The $3,221.57 contract is for the supply of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product. This delivery order is issued under an indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with a potential value of $999,999,999.00 through December 31, 2025. The IDC allows Amerisourcebergen to provide a comprehensive range of...
- SPE2DB22D2108Indefinite Delivery Contract
- SPE2DB22D2108-SPE2DB24FU3VCDelivery Order
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of XIFAXAN 550 MG TABLET 60S. The contract has a firm fixed price of $15,020.56 and a period of performance through April 29, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. The IDC serves as the primary vehicle for Cencora, Inc. to provide a comprehensive range of pharmaceutical products and medical supplies to support the healthcare needs of the Department of Defense and other federal agencies. This particular delivery order was awarded through full and open competition without any set-aside designations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.0k | 4/26/24 |